Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Features

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Michael O'Riordan

January 17, 2025

News Features

Reimbursement Issues Seem to Be Holding Renal Denervation Back

Todd Neale

December 19, 2024

News Features

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

L.A. McKeown

August 09, 2024

News Features

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

Michael O'Riordan

January 06, 2023

News Features

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

L.A. McKeown

December 02, 2022

News Features

Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay?

Todd Neale

December 09, 2021

News Features

Roughly 80% of ESC Guideline Writers Have Financial COIs

Michael O'Riordan

April 01, 2021

News Features

Funding the Future: How Industry Support for CV Trials Could Evolve

Michael O'Riordan

December 17, 2020

News Features

Cardiology After COVID-19: Physicians Predict Lasting Change

Yael L. Maxwell

May 20, 2020

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

News Features

ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging

Michael O'Riordan

March 23, 2018

News Features

Mercury Rising: As Doctors’ Groups Face Off Over BP Guidelines, Will Patients Fall Through the Cracks?

L.A. McKeown

February 26, 2018

News Features

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Michael O'Riordan

May 08, 2017

News Features

Be It Resolved: E-Cigarettes May Help Smokers Cut Back, but Quit Altogether? The Jury’s Out

Caitlin E. Cox

January 20, 2017

Advertisement

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Reimbursement Issues Seem to Be Holding Renal Denervation Back

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay?

Roughly 80% of ESC Guideline Writers Have Financial COIs

Funding the Future: How Industry Support for CV Trials Could Evolve

Cardiology After COVID-19: Physicians Predict Lasting Change

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging

Mercury Rising: As Doctors’ Groups Face Off Over BP Guidelines, Will Patients Fall Through the Cracks?

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Be It Resolved: E-Cigarettes May Help Smokers Cut Back, but Quit Altogether? The Jury’s Out

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content